EFFECT OF CHLORPROMAZINE ON LEVELS OF ADENINE NUCLEOTIDES AND CREATINE PHOSPHATE OF BRAIN
1961; Wiley; Volume: 7; Issue: 3 Linguagem: Inglês
10.1111/j.1471-4159.1961.tb13502.x
ISSN1471-4159
AutoresNorman Weiner, Harriett N. Huls,
Tópico(s)Enzyme function and inhibition
ResumoJournal of NeurochemistryVolume 7, Issue 3 p. 180-185 EFFECT OF CHLORPROMAZINE ON LEVELS OF ADENINE NUCLEOTIDES AND CREATINE PHOSPHATE OF BRAIN Norman Weiner, Norman Weiner Department of Pharmacology, Harvard Medical School, Boston 15, MassachusettsSearch for more papers by this authorHarriett N. Huls, Harriett N. Huls Department of Pharmacology, Harvard Medical School, Boston 15, MassachusettsSearch for more papers by this author Norman Weiner, Norman Weiner Department of Pharmacology, Harvard Medical School, Boston 15, MassachusettsSearch for more papers by this authorHarriett N. Huls, Harriett N. Huls Department of Pharmacology, Harvard Medical School, Boston 15, MassachusettsSearch for more papers by this author First published: July 1961 https://doi.org/10.1111/j.1471-4159.1961.tb13502.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES Abood L. G. (1955) Proc. Soc. exp. Biol., N. Y. 88, 688. Andrejew A., Ducet G., Louw J. and Rosenberg A. J. (1956a) C.R. Soc. Biol., Paris, 150, 484. Andrejew A., Ducet G., Louw J. and Rosenberg A. J. (1956b) C.R. Soc. Biol., Paris, 150, 509. Andrejew A. and Rosenberg A. J. (1957) C.R. Soc. Biol., Paris, 151, 237. Ansell G. B. and Dohman H. (1956) J. Neurochem. 1, 150. Berger M. (1957) J. Neurochem. 2, 30. Bernsohn J., Namajuska I. and Boshes B. (1956) J. Neurochem. 1, 145. Bernsohn J., Namajuska I. and Cochrane L. S. G. (1955) Fed. Proc. 14, 182. Century B. and Horwiit M. K. (1956) Proc. Soc. exp. Biol., N.Y. 91, 493. Christensen I. and Wase A. W. (1956) Acta pharm. tox., Kbh. 12, 81. Dawkins M. J. R., Judah I. D. and Rees K. R. (1959a) Biochem. J. 72, 201. Dawkins M. J. R., Judah J. D. and Rees K. R. (1959b) Biochem. J. 73, 16. Decsi L. and Méhes J. (1957) Arch. exp. Path. Pharmak. 230, 462. Ennor A. H. and Rosenberg H. (1952) Biochem. J. 51, 606. Erdös E. G., Baart N., Shanor S. P. and Foldes F. F. (1958) Arch. int. Pharmacodyn. 117, 163. Finklestein M., Spencer W. A. and Ridgeway E. R. (1954) Proc. Soc. exp. Biol., N.Y. 87, 343. Grenell R. G., May L., Mendelson J. and McElroy W. D. (1959) Res. Publ. Ass. nerv. ment. Dis. 37, 417. Grenell R. G., Mendelson I. and McElroy W. D. (1955) Arch. Neurol. Psychiat., Lond. 73, 347. Kalckar H. M. (1947) J. biol. Chem. 167, 445. Kerr S. E. (1935) J. biol. Chem. 110, 625. Lasslo A. and Meyer A. L. (1959) Nature, Lond. 184, 1922. Lindan O., Quastel J. H. and Sved S. (1957a) Canad. J. Biochem. Physiol. 35, 1135. Lindan O., Quastel J. H. and Sved S. (1957b) Canad. J. Biochem. Physiol. 35, 1145. McIlwain H. (1959) Biochemistry and the Central Nervous System. Little. Brown, Boston , Mass . McIlwain H. and Greengard O. (1957) J. Neurochem. 1, 348. Messer M. (1958) Aust. J. exp. Biol. med. Sci. 36, 65. Rau G. C., Auyong T., Paradise R. R., Baumgardt J. P. and Eisenbrandt L. L. (1956) J. Pharmacol. 116, 48. Richter D. (1957) In Psychotropic Drugs (Edited by S. Garaitni and V. Gmrn) Elsevier, Amsterdam . Salzman N. P. and Brodie B. B. (1956) J. Pharmacol. 118, 46. Weiner N. (1961) J. Neurochem. In Press. Yagi K., Nagatsu T. and Ozawa T. (1956) Nature, Lond. 177, 891. Citing Literature Volume7, Issue3July 1961Pages 180-185 ReferencesRelatedInformation
Referência(s)